Nectar Lifesciences

From Wikipedia, the free encyclopedia

Nectar Lifesciences Limited
Type Public (BSE: NECLIFE)
Founded 1995
Headquarters Chandigarh, India
Key people Sanjiv Goyal, Chairman and Managing Director
Industry Pharmaceuticals
Products Cephalosporins, Phytochemicals
Revenue INR 4.6 billion
Net income INR 460 million
Employees 1200
Website Nectar Lifesciences
Nectar Lifesciences Finished Dosage Facility
Nectar Lifesciences Finished Dosage Facility

Nectar Lifesciences Limited is an integrated pharmaceutical company in India that manufactures generic products.

Contents

[edit] History

The company was promoted by Sanjiv Goyal and incorporated in June 1995 as Surya Medicare Limited, with financial collaboration from the Punjab State Industrial Development Corp. (PSIDC). Its name was changed to Nectar Lifesciences in Mar. 2004 after it bought out PSIDC. Nectar Lifesciences went public in July 2005 with simultaneous listings on Bombay Stock Exchange and the National Stock Exchange of India.

[edit] Market Cap

The current market capitalization is about INR 3 billion (US$ 80 million).

[edit] Products

Nectar Lifesciences manufactures oral and sterile active pharmaceutical ingredients, finished dosages and phytochemicals. The company is also in business of providing leading pharmaceutical organizations with contract research and manufacturing services. It also Manufactures Empty Hard Gelatin Capsules.

[edit] Cephalosporins

[edit] Phytochemicals (Plant Extracts)

[edit] External links